治疗中期超声描述符作为三阴性乳腺癌病理完全缓解的定性影像学生物标志物
本研究纳入144例三阴性乳腺癌患者,在完成四周期蒽环类化疗后、紫杉类化疗前行超声检查,盲法共识阅片评估肿瘤反应模式和肿瘤表现。单因素及多因素回归分析显示,治疗中期反应模式与病理完全缓解显著相关(p=0.0348和p=0.0173),完全型和同心圆型反应模式更可能达到病理完全缓解;肿瘤表现与病理完全缓解也显著相关(两者p<0.0001),持续肿块表现较其他表现更不可能达到病理完全缓解。作者认为这些参数有潜力作为三阴性乳腺癌病理完全缓解的定性影像学生物标志物。
要点
- 治疗中期超声评估的完全型和同心圆型反应模式更可能达到病理完全缓解。
- 治疗中期持续肿块表现较其他表现更不可能达到病理完全缓解。
- 肿瘤反应模式和肿瘤表现与病理完全缓解均显著相关,可能作为定性影像学生物标志物。
核心结论
- 治疗中期超声的肿瘤反应模式和肿瘤表现与三阴性乳腺癌病理完全缓解强相关,提示这些参数有潜力作为病理完全缓解的定性影像学生物标志物。
研究设计与样本
- 研究纳入144例三阴性乳腺癌患者,在完成四周期蒽环类化疗后、接受紫杉类化疗前行超声检查,采用盲法共识阅片,以手术病理病理完全缓解/非病理完全缓解为参考标准,行单因素和多因素回归分析。
关键影像表现/征象
- 肿瘤反应模式分为完全型、同心圆型、碎片型、稳定型和进展型。
- 肿瘤表现分为肿块型、结构扭曲型、平坦瘤床型和仅夹标型。
- 完全型和同心圆型反应模式较其他模式更可能达到病理完全缓解。
- 持续肿块表现较其他表现更不可能达到病理完全缓解。
诊断标准与关键数值
- 治疗中期反应模式与病理完全缓解相关:单因素分析p=0.0348,多因素分析p=0.0173。
- 治疗中期肿瘤表现与病理完全缓解相关:单因素和多因素分析均p<0.0001。
临床应用与阅片要点
- 治疗中期超声阅片时可按完全型、同心圆型、碎片型、稳定型、进展型描述肿瘤反应模式。
- 治疗中期超声可留意肿瘤表现为肿块型、结构扭曲型、平坦瘤床型或仅夹标型。
- 完全型和同心圆型反应模式提示更可能达到病理完全缓解,持续肿块表现提示更不可能达到病理完全缓解。
- 作者认为肿瘤反应模式和肿瘤表现有潜力作为病理完全缓解的定性影像学生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This study aimed to investigate mid-treatment breast tumor ultrasound characteristics that may predict eventual pathologic complete response (pCR) in triple-negative breast cancer; specifically, we examined associations between pCR and two parameters: tumor response pattern and tumor appearance. Ultrasound was performed at mid-treatment, defined as the completion of four cycles of anthracycline-based chemotherapy and before receiving taxane-based chemotherapy. Consensus imaging review was performed while blinded to pathology results (i.e., pCR/non-pCR) from surgery. Tumor response pattern was described as "complete," "concentric," "fragmented," "stable" or "progression." Tumor appearance was designated as "mass," "architectural distortion," "flat tumor bed" or "clip only." Univariate and multivariate regression analyses of 144 participants showed significant associations between mid-treatment response pattern and pCR (p = 0.0348 and p = 0.0173, respectively), with complete and concentric response patterns more likely to achieve pCR than other patterns. Univariate and multivariate regression analyses further showed significant associations between mid-treatment tumor appearance and pCR (p < 0.0001 for both), with persistent appearance of mass less likely than other appearances to achieve pCR. To conclude, our study demonstrated strong associations between pCR and both tumor response pattern and tumor appearance, thereby suggesting that these parameters have potential as qualitative imaging biomarkers of pCR in triple-negative breast cancer.
引用
- Candelaria, Adrada, Lane, et al. Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer. Ultrasound Med Biol. 2022. PMID: 35300879. doi:10.1016/j.ultrasmedbio.2022.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。